XWELL, Inc.

Xwell, Inc.

Diagnostics & Research • Healthcare • New York, NY, United States • XWEL (NCM)

XWELL, Inc. provides health and wellness services to travelers in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment provides traveler's spa services, including massage, and nail and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests to airport employees and traveling public at XpresCheck Wellness Centers in airports; operates the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels. The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services. The Treat segment provides access to wellness services for travelers at on-site centers. The company offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022. XWELL, Inc. is based in New York, New York.

212 750 9595 254 West 31st Street, New York, NY 10001, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Stock Market Recap: Is XWEL stock trading near support levels - Dividend Hike & Daily Growth Stock Investment Tips - moha.gov.vn
moha.gov.vn • Dec 29
XWELL Shareholders Approve Reverse Split, Capital Flexibility Moves - The Globe and Mail
The Globe and Mail • Dec 19
XWELL (Nasdaq: XWEL) trims costs as Q3 revenue hits $7.3M; operating loss $0.8M - Stock Titan
Stock Titan • Nov 14
XWELL, Inc. Reports Third Quarter 2025 Results, Expands Global Partnership and Streamlines Operations - Quiver Quantitative
Quiver Quantitative • Nov 14
Xwell cancels annual shareholder meeting and withdraws proposals - Investing.com
Investing.com • Oct 9

Other Diagnostics & Research Companies

View All →
THERMO FISHER SCIENTIFIC INC. logo Thermo Fisher Scientific Inc.
$219.82B market cap
DANAHER CORP /DE/ logo Danaher Corp.
$165.14B market cap
IDEXX LABORATORIES INC /DE logo Idexx Laboratories Inc.
$55.08B market cap
AGILENT TECHNOLOGIES, INC. logo Agilent Technologies, Inc.
$39.23B market cap
IQVIA HOLDINGS INC. logo Iqvia Holdings Inc.
$38.49B market cap
Natera, Inc. logo Natera, Inc.
$32.25B market cap

Frequently Asked Questions

Has XWELL, Inc. had layoffs?
No layoff events have been recorded for XWELL, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does XWELL, Inc. have?
XWELL, Inc. has approximately 246 employees.
What industry is XWELL, Inc. in?
XWELL, Inc. operates in the Diagnostics & Research industry, within the Healthcare sector.
Is XWELL, Inc. a publicly traded company?
Yes, XWELL, Inc. is publicly traded under the ticker symbol XWEL on the NCM. The company has a market capitalization of approximately $0.00 billion.
Where is XWELL, Inc. headquartered?
XWELL, Inc. is headquartered in New York, NY, United States at 254 West 31st Street, New York, NY 10001, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.